Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Wound Debridement Market size was over USD 6.95 billion in 2024 and is anticipated to cross USD 15.38 billion by 2037, growing at more than 6.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of wound debridement is estimated at USD 7.32 billion.
Increasing incidence of wounds due to diabetes, venous leg ulcers and surgeries are expected to fuel the progress of this market. The growth of the market can also be attributed to factors such as the increasing geriatric population and increasing wound infections. According to the research, the annual incidence of diabetic foot ulcer worldwide is between 9.1 to 26.1 million.
Wound Debridement Sector: Growth Drivers and Challenges
Growth Drivers
- Growing incidence of pressure ulcers, diabetic foot and surgical procedures
- Rise in the incidence of wound infections
Challenges
- High treatment cost
Wound Debridement Segmentation
The market is segmented based on product into gel and ointment, medical debridement pads, medical gauzes, enzymatic debridement products and, others, out of which, the gels segment is anticipated to grab the largest share by the end of 2021 as gels are having property to avoid enzymatic activity and drug interaction with food and drinks. In addition, no inflammation, less bleeding, removal of necrotic tissue safely and without infection are some factors that are contributing to the growth of this segment.
On the basis of application, diabetic foot ulcers are observed as the fastest growing segment due to increasing prevalence of diabetes. Furthermore, pressure ulcers are anticipated to hold the largest share in the market in owing to increasing incidence of bedsores. In addition, skin of aged people is highly sensitive and is more prone towards developing bedsores, thereby bolstering the growth of the segment.
Our in-depth analysis of the global market includes the following segments:
|
By Therapy Type |
|
|
By Wound Type |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportWound Debridement Industry - Regional Synopsis
Asia Pacific industry is anticipated to account for largest revenue share by 2037, due to booming economies, and reforms to improve healthcare infrastructure facilities in the region. Furthermore, in 2021, the market in North America is evaluated to occupy the largest share in terms of revenue, the growth of the region can be attributed to the presence of developed medical infrastructure and increasing patient awareness coupled with rising disposable income and soaring need for quality medical products and services. As per the analysis of American Diabetes Association, diabetes affects 30 million people in the US and more than 415 million people worldwide.
Companies Dominating the Wound Debridement Landscape
- B. Braun Melsungen AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Smith & Nephew plc
- Coloplast A/S
- ConvaTec Group Plc
- Mölnlycke Health Care
- Lohmann & Rauscher
- Integra Lifesciences Holdings Corporation
- Zimmer Biomet Holdings Inc.
- Misonix Inc.
- MediWound Ltd.
In the News
Author Credits: Radhika Pawar
- Report ID: 2958
- Published Date: Dec 26, 2024
- Report Format: PDF, PPT
